On December 2, 2016, 7 members of the International Myeloma Foundation (IMF) Nurse Leadership Board convened in San Diego, California, in concurrence with the American Society of Hematology (ASH) Annual Meeting, to discuss the following topics as they relate to the current therapeutic landscape and the patient experience: 

1.  Current therapeutic landscape 
2.  Patient challenges and education opportunities 
3.  Unmet needs and best practices for patient care
4.  Potential solutions to overcoming barriers and optimizing care